Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 24.3 | 14.2 | 0.0 | |
| Revenue growth | 71.1% | | | |
| Cost of goods sold | 18.1 | 10.9 | 0.0 | |
| Gross profit | 6.2 | 3.3 | 0.0 | |
| Gross margin | 25.4% | 23.5% | | |
| Sales and marketing | 6.9 | 5.0 | 0.0 | |
| Research and development | 3.7 | 1.7 | 1.8 | |
| General and administrative | 18.7 | 10.5 | 1.5 | |
| EBITA | -25.6 | -15.3 | -3.4 | |
| EBITA margin | -105.1% | -107.4% | | |
| Amortization of intangibles | 0.8 | 0.6 | | |
| EBIT | -26.4 | -15.9 | -3.4 | |
| EBIT margin | -108.5% | -111.5% | | |
| Pre-tax income | -27.0 | -16.1 | -3.9 | |
| Income taxes | -0.5 | -0.2 | 0.0 | |
| Tax rate | 1.9% | 0.9% | 0.0% | |
| Net income | -26.5 | -16.0 | -3.9 | |
| Net margin | -108.7% | -112.4% | | |
| |
| Diluted EPS | ($1.31) | ($1.59) | ($1.59) | |
| Shares outstanding (diluted) | 20.2 | 10.1 | 2.4 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|